56 results
S-1
EX-10.12
AGIO
Agios Pharmaceuticals Inc
10 Jun 13
IPO registration
12:00am
), or in such lesser amounts as Landlord may accept, covering personal injury and death and property damage (all such insurance to be written in companies approved … , servants or employees, or arising from any accident, injury or damage whatsoever caused to any person or property, occurring after the date that possession
8-K
EX-10.1
AGIO
Agios Pharmaceuticals Inc
19 Sep 14
Entry into a Material Definitive Agreement
12:00am
, covering personal injury and death and property damage (all such insurance to be written in companies approved reasonably by the Landlord and insuring … contractors, licensees, invitees, agents, servants or employees, or arising from any accident, injury or damage whatsoever caused to any person
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
28 Oct 19
Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study ofAG-270, a MAT2A Inhibitor, in Patients withMTAP-Deleted Tumors
7:20am
.
For patients treated in the 200 mg twice daily cohort, two of six experienced reversible acute liver injury, manifested as asymptomatic Grade 3 and 4
8-K
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
Policies” means all insurance policies of Seller and its Affiliates relating to product liability, product defects, product recalls and personal injury … recall, product defect and personal injury from Products or clinical trials related to the Business;
(e) Any and all Liabilities with respect to any
DEFA14A
EX-2.1
zahel0wo lgrs45
21 Dec 20
Additional proxy soliciting materials
9:17pm
10-Q
1tg4ra0od3y6 z3bem
5 Sep 13
Quarterly report
12:00am
PREM14A
wmeprlaj
29 Jan 21
Preliminary proxy related to merger
4:22pm
DEFM14A
obudd
11 Feb 21
Proxy related to merger
4:19pm
10-K
cyoxpq8l4xoeph2 ajrc
18 Mar 14
Annual report
12:00am